The growing impact of human papilloma virus (HPV)-associated cancers in men in Costa Rica: epidemiological and economic burden
- PMID: 40606119
- PMCID: PMC12213727
- DOI: 10.3389/fpubh.2025.1487256
The growing impact of human papilloma virus (HPV)-associated cancers in men in Costa Rica: epidemiological and economic burden
Abstract
Human papillomavirus (HPV) is the most common sexually transmitted infection in men and women and is responsible for a substantial burden of disease worldwide. Although HPV-related disease burden is high in women due to cervical related disease and cancer, men are directly affected by HPV. According to the World Health Organization (WHO), one in three men has a prevalent HPV infection worldwide. Currently, there is a lack of data regarding the epidemiology and healthcare resource utilization (HCRU) of HPV-associated cancers among Costa Rican men. This study aimed to describe the epidemiological characteristics of HPV-associated male cancer and disease and the HCRU in Costa Rica. HPV-related cancers in men were assessed through retrospective database study for epidemiology and Delphi panel with five experts for HCRU. A total of 1,340 men with penile, anal, and head and neck cancers between 2012 and 2016 were identified in the database, with a mean age of 63.6 years. Anal cancer accounted for 48% of cases, followed by head and neck 44%, and penile cancer 11%. The cumulative rate of HPV-associated cancer in men per 100,000 population increased from 8.6 in 2012 to 55.5 in 2016. According to 4/5 panelists, resources for the disease management were also scarce. Panelists agreed that the cost for HPV management within their institution was 0.6-40,000 USD. Despite the increasing incidence e of HPV-related cancer in men, HPV prevention in men continues to be an under-served issue in public policy that could result in substantial economic and clinical burden. National health authorities should promote strategies to prevent HPV infections and associated diseases among Costa Rican men.
Keywords: HPV-related cancer; anal cancer; human papilloma virus; human papilloma virus related disease; male HPV-disease.
Copyright © 2025 Ospina-Henao, Brenes-Castillo, Marcano-Lozada, Betancur-Díaz, Medina, Brenes-Chacon and Avila-Aguero.
Conflict of interest statement
MB-D and SM are Merck Sharp and Dohme (MSD) Colombia employees. MM-L was employed by Merck Sharp and Dohme (MSD). The authors declare that this study received funding from Merck Sharp and Dohme (MSD). The funder had the following involvement in the study: design, collection, analysis, interpretation of data and the writing of this article.
Figures
Similar articles
-
Disparities in Human Papillomavirus-Associated Cancer Incidence by Appalachian Residence.JAMA Netw Open. 2025 Jun 2;8(6):e2518242. doi: 10.1001/jamanetworkopen.2025.18242. JAMA Netw Open. 2025. PMID: 40587129 Free PMC article.
-
HPV cancer burden by anatomical site, country, and region in 2022.Sci Rep. 2025 Jul 1;15(1):21048. doi: 10.1038/s41598-025-06700-8. Sci Rep. 2025. PMID: 40593150 Free PMC article.
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Changes in incidence of HPV-related cancers in South Africa (2011-21): a cross-sectional analysis of the South African National Cancer Registry.Lancet Glob Health. 2025 Jun;13(6):e1101-e1110. doi: 10.1016/S2214-109X(25)00065-8. Lancet Glob Health. 2025. PMID: 40412399 Free PMC article.
-
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article.
References
-
- Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol. (2017) 40:80–5. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical